Creating New Products and Making Upfront Investments in R&D
First written in FY2022-Q2. 11 of 15 entries say "Restated". Latest entry: FY2026.
46 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The company is developing technology and solution assets with Joint R&D partners across various industries, with a view to leveraging private-sector data within each industry.」
The company continues to jointly develop technologies with Joint R&D partners and build technology and solution assets using private-sector data. No research and development expenses were incurred during the consolidated fiscal year. - FY2026-H1RestatedAnnual report
「The company is developing technology and solution assets for Joint R&D partners in various industries and for the use of private data within those industries. No R&D expenses were incurred by the Group during the interim consolidated accounting period.」
The company continues to develop technology and solution assets with Joint R&D partners. Meanwhile, it states that there were no R&D expenses during the interim consolidated accounting period. - FY2025-H1RestatedAnnual report
「In addition to its traditional labor-intensive businesses, such as support for the use of DX and AI implementation, the Group also seeks to generate non-labor-intensive revenue centered on its proprietary AI solutions, and continued to focus on winning AI solution development projects, R&D and active recruitment as upfront investment. There were no R&D expenses incurred by the Group during the interim consolidated accounting period.」
The company continues to uphold upfront investment in its proprietary AI solutions, Joint R&D, R&D and recruitment. It states that no R&D expenses were incurred during the interim consolidated accounting period. - FY2024-Q3RestatedAnnual report
「Operating profit amounted to ¥46.132 million, down 31.3% year on year, as the company continued active upfront investment in winning AI solution development projects (Joint R&D), planning and developing products and platforms, and recruiting personnel.」
The company continues upfront investment in Joint R&D, product and platform planning and development, and recruitment. Total R&D expenses were ¥42,000. - FY2024-Q2RestatedAnnual report
「Operating profit amounted to ¥5.216 million, down 90.3% year on year, as the company continued active upfront investment in winning AI solution development projects (Joint R&D), planning and developing products and platforms, and recruiting personnel.」
The company continues upfront investment in Joint R&D, product and platform planning and development, and recruitment. Total R&D expenses are reported as ¥42,000. - FY2024-Q1RestatedAnnual report
「Operating loss amounted to ¥50.191 million, as the company continued active upfront investment in winning AI solution development projects (Joint R&D), planning and developing products and platforms, and recruiting personnel. Total R&D expenses incurred by the company during the cumulative first quarter amounted to ¥42,000.」
The company continues upfront investment in Joint R&D, product and platform development, and recruitment. R&D expenses of ¥42,000 were disclosed. - FY2023RestatedAnnual report
「As a result, total R&D expenses for the consolidated fiscal year amounted to ¥29.755 million.」
The company continues R&D of AI solutions to solve common industry challenges and recorded R&D expenses of ¥29.755 million for the consolidated fiscal year. - FY2023-Q3RestatedAnnual report
「The Group’s total R&D expenses for the cumulative third quarter amounted to ¥34.039 million, with particular efforts focused on R&D of new algorithms and software in the AI Solutions business.」
The company continues R&D of new algorithms and software in the AI Solutions business, and total R&D expenses were ¥34.039 million. - FY2023-Q2RestatedAnnual report
「The Group’s total R&D expenses for the cumulative second quarter amounted to ¥26.911 million, with particular efforts focused on R&D of new algorithms and software in the AI Solutions business.」
The company continues R&D of new algorithms and software, and reports total R&D expenses of ¥26.911 million. - FY2023-Q1RestatedAnnual report
「Operating profit amounted to ¥44.044 million, down 13.2% year on year, following continued active upfront investment in creating new products, R&D and recruitment.」
The company continues upfront investment in new products, R&D and recruitment. R&D expenses for the cumulative first quarter were ¥10.250 million. - FY2022AdvancedAnnual report
「During the fiscal year, the company conducted cross-functional R&D activities focused on demand forecasting, price optimization, marketing optimization and data platform development. The results of this R&D are linked to the company’s AI solutions and their functions.」
The company expanded its R&D themes to demand forecasting, price optimization, marketing optimization and data platform development, and recorded R&D expenses of ¥173.235 million. - FY2022-Q3RestatedAnnual report
「Operating results were a loss of ¥55.082 million, following continued active upfront investment in creating new products, R&D and recruitment. Total R&D expenses incurred by the company during the cumulative third quarter amounted to ¥130.886 million.」
The company continues upfront investment in new products, R&D and recruitment, and reports total R&D expenses of ¥130.886 million. - FY2022-Q2First statedAnnual report
「Operating profit amounted to ¥19.196 million, following continued active upfront investment in creating new products, R&D and recruitment.」
The company is pursuing the creation of new products and R&D as upfront investments, and reports total R&D expenses of ¥76.558 million for the cumulative second quarter.